Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial

Affiliations

• ¹ Abcentra, 1925 Century Park E #1700, Los Angeles, CA 90067, USA.
• ² Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.
• ³ Department of Cardiology and Smidt Heart Institute, Oppenheimer Atherosclerosis Research Center, Cedars Sinai Medical Center, Los Angeles, CA, USA.
• ⁴ Caristo Diagnostics, Oxford, UK.
• ⁵ Radcliffe Department of Medicine, Division of Cardiovascular Medicine, Acute Multidisciplinary Imaging and Interventional Centre, University of Oxford, UK.
• ⁶ Department of Clinical Sciences Malmö, Lund University, Jan Waldenströms gata 35, 20502 Malmö, Sweden.
• ⁷ Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.